Castle Biosciences Reports Third Quarter 2025 Results
Provided By GlobeNewswire
Last update: Nov 3, 2025
Delivered Q3 2025 revenue of $83 million
Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024
Read more at globenewswire.comProvided By GlobeNewswire
Last update: Nov 3, 2025
Delivered Q3 2025 revenue of $83 million
Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024
Read more at globenewswire.com
